Rockwell Medical (RMTI) Return on Capital Employed (2011 - 2026)

Rockwell Medical has reported Return on Capital Employed for 16 years, with the latest figure at 10.15% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 1141.0% year-over-year to 10.15%; the trailing twelve-month figure through Mar 2026 stood at 10.15% (down 1141.0% YoY), and the FY2025 full-year result was 9.65%, down 1111.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 10.15%, down from 9.83% in the prior quarter.
• The five-year high for Return on Capital Employed was 1.42% in Q3 2024, with the low at 127.21% in Q1 2022.
• Historically, Return on Capital Employed has averaged 30.86% across 5 years, with a median of 17.99% in 2024.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 8304 bps — and 2023, when it soared 8654 bps.
• Rockwell Medical's Return on Capital Employed stood at 51.29% in 2022, then jumped by 64 bps to 18.66% in 2023, then surged by 107 bps to 1.38% in 2024, then slumped by 812 bps to 9.83% in 2025, then declined by 3 bps to 10.15% in 2026.
• The last three Return on Capital Employed figures came in at 10.15% (Q1 2026), 9.83% (Q4 2025), and 10.58% (Q3 2025), per Business Quant data.